Mitesh

In response to a significant ongoing disruption to the supply of Lipitor® 20mg chewable tablets , a Serious Shortage Protocol (SSP) has been issued by the Department of Health and Social Care (DHSC). Effective today, 23 November 2022, SSP039 provides that for every Lipitor® 20mg chewable tablet originally prescribed, either one Atorvastatin 20mg tablet or the equivalent [...]

The post New SSP issued for Lipitor® 20mg chewable tablets appeared first on PSNC Website.

The Department of Health and Social Care (DHSC) has confirmed that sufficient stock of Estraderm MX® 50mcg patches are now available to meet normal demand. As a result the Serious Shortage Protocol (SSP), SSP037 Estraderm MX® 50mcg patches expires at 23.59pm on Wednesday 23 November 2022. After this date, any prescriptions for Estraderm MX® 50mcg [...]

The post Contractor Notice: Expiry of SSP037 Estraderm MX® 50mcg patches appeared first on PSNC Website.

Class 4 Medicines Defect Information: Hyoscine Butylbromide 20 mg film-coated tablets (Morningside Healthcare Limited) Drug alert number: EL (22)A/48 Date issued: 21 November 2022 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Hyoscine Butylbromide 20 mg film-coated tablets, PL 20117/0349 Batch Number Expiry Date Pack [...]

The post MHRA – Class 4 Medicines Defect Information: Hyoscine Butylbromide 20 mg film-coated tablets (Morningside Healthcare Limited) appeared first on PSNC Website.

The Department of Health and Social Care (DHSC) has today (18/11/2022) granted the following initial list of price concessions for November 2022: Drug Pack size Price concession Amoxicillin 250mg/5ml oral suspension 100 £2.69 Amoxicillin 250mg/5ml oral suspension sugar free 100 £2.69 Benzydamine 0.15% mouthwash sugar free 300 £4.65 Bisacodyl 5mg gastro-resistant tablets 60 £4.99 Bisoprolol [...]

The post November 2022 Price Concessions 1st Update appeared first on PSNC Website.

In response to a significant ongoing disruption to the supply of Estraderm MX® 50mcg and 75mcg patches, two new Serious Shortage Protocols (SSPs) have been issued by the Department of Health and Social Care (DHSC). Effective 15 November 2022, SSP037 and SSP038 provides for the following: SSP037 – for every Estraderm MX® 50mcg  patch originally prescribed, one [...]

The post Two SSPs issued for Estraderm® MX 50mcg and 75mcg patches appeared first on PSNC Website.